R-CHOP/Ibrutinib Alternating with R-DHAP Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen that alternates rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) and ibrutinib with rituximab, dexamethasone, high-dose cytarabine and cisplatin (R-DHAP) that can be used in the treatment of mantle cell lymphoma.

**Synonyms:** - Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine Plus Ibrutinib Alternating with Rituximab Plus Cisplatin/Cytarabine/Dexamethasone - Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine/Ibrutinib-Rituximab/Cisplatin/Cytarabine/Dexamethasone - IR-CHOP/R-DHAP - IR-CHOP/R-DHAP (rituximab-abbs) - IR-CHOP/R-DHAP (rituximab-arrx) - IR-CHOP/R-DHAP (rituximab-blit) - IR-CHOP/R-DHAP (rituximab-pvvr) - IR-CHOP/R-DHAP (rituximab-rite) - IR-CHOP/R-DHAP (rituximab-rixa) - IR-CHOP/R-DHAP (rituximab-rixi) - R-CHOP-Ibrutinib Alternating with R-DHAP - R-CHOP-Ibrutinib/R-DHAP - R-CHOP-Ibrutinib/R-DHAP Regimen